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Summary Ameloblasts secrete enamel matrix proteins, including amelogenin, ameloblastin,
enamelin, amelotin, and Apin/odontogenic ameloblast-associated protein (Apin/ODAM). Ame-
logenin is the major protein component of the enamel matrix. Amelogenin, ameloblastin, and
enamelin are expressed during the secretory stage of ameloblast, while amelotin and Apin/ODAM
are expressed during the maturation. Amelogenin and ameloblastin are also expressed in
osteoblasts, and they regulate bone formation. In addition, recent studies show the importance
of protein—protein interactions between enamel matrix components for enamel formation. In a
mouse model mimicking a mutation of the amelogenin gene in amelogenesis imperfect (AI) in
humans, the mutated amelogenin forms a complex with ameloblastin, which accumulates in the
endoplasmic reticulum/Golgi apparatus and causes ameloblast dysfunction resulting in AI
phenotypes. Ameloblastin is a cell adhesion molecule that regulates cell proliferation. It inhibits
odontogenic tumor formation and regulates osteoblast differentiation through binding to CD63.
Amelotin interacts with Apin/ODAM, but not ameloblastin, while Apin/ODAM binds to amelo-
blastin. These interactions may be important for enamel mineralization during amelogenesis. The
enamel matrix genes are clustered on human chromosome 4 except for the amelogenin genes
located on the sex chromosomes. Genes for these enamel matrix proteins evolved from a common
ancestral gene encoding secretory calcium-binding phosphoprotein.
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Dental enamel, known as the hardest tissue in vertebrates, is
formed by ameloblasts derived from the oral epithelium. In
the initial stage of the enamel organ’s development, the oral
epithelium invades the dental mesenchyme, followed by
differentiation into four types of epithelial cells, including
the inner enamel epithelium, the stratum intermedium, the
stellate reticulum, and the outer enamel epithelium. Among
these cell types, the inner enamel epithelium differentiates
into enamel matrix-secreting ameloblasts. The formation of
dental enamel is a prototype of functional organ develop-
ment through a matrix mineralization process (Fig. 1). Unlike
dentin and bone matrices, in which collagen I is the major
matrix protein, enamel matrices consist of a distinct set of
matrix molecules with amelogenin being the major compo-
nent. The different matrix components in enamel contribute
to its larger and more rigid hydroxyapatite crystal structures
than dentin and bone. Enamel matrix proteins are produced
at their highest levels by ameloblasts during the secretory
and transition stages of amelogenesis and collectively
orchestrate the proper assembly and growth of crystals
within mineralized enamel. These proteins are nearlyFigure 1 Oral epithelium differentiates into four types of den
intermedium, and stellate reticulum. Inner enamel epithelium dif
epithelium and pre-ameloblast secrete and bind to basement membr
AMBN, and ENAM. Maturation-stage ameloblasts secrete AMTN and completely degraded by specific proteases such as MMP-
20, mainly produced during the secretory/transition stage,
and KLK4, mainly produced during the transition/maturation
stage, resulting in a highly ordered and purposefully designed
meshwork of carbonated hydroxyapatite crystals with aston-
ishing mechanical properties [1].
Cell adhesion to the extracellular matrix is of fundamental
importance for a wide range of cellular functions, including
cell differentiation, proliferation, and survival [2]. Inner and
outer enamel epithelial cells interact with the basement
membrane, of which major constituents are type IV collagen,
laminin, and heparan-sulfate proteoglycan perlecan. For
example, laminin a5 (Lama5)-deficient mice show small tooth
germs without a cusp [3]. In addition, proliferation and polar-
ization of the dental epithelium are inhibited in these mice,
indicating that interactions between the dental epithelium
and the basement membrane are important to determine
tooth sizes and dental epithelial cell differentiation.
Ameloblasts are polarized in the secretory stage and
secrete enamel matrix components, including amelogenin
(AMEL), ameloblastin (AMBN), and enamelin (ENAM).
Furthermore, amelotin (AMTN) and Apin/odontogenic ame-
loblast-associated (ODAM) are secreted from those in thetal epithelium: inner and outer enamel epithelium, stratum
ferentiates into pre-ameloblast and ameloblast. Inner enamel
ane. Secretory-stage ameloblasts secrete enamel matrices AMEL,
Apin/ODAM.
Table 1 Summary of enamel matrix.
Matrix name
(abbreviation)
Expression Human cytogenetic
localization
Mouse KO phenotype Reference
Amelogenin (AMEL) Ameloblast (secretory),
odontoblast, osteoblast,
cementoblast, epithelial
rests of Malassez
Xp22.2 (AMELX),
Yp11.2 (AMELY)
Amelogenesis imperfecta
tooth root resorption
reduced bone formation
[9]
Ameloblastin (AMBN) Ameloblast (secretory),
odontoblast, osteoblast,
cementoblast, epithelial
rests of Malassez
4q13.3 Amelogenesis imperfecta
reduced bone formation
tumor formation
[18]
Enamelin (ENAM) Ameloblast (secretory) 4q13.3 Amelogenesis imperfecta
(ENU induced)
[33]
Amelotin (AMTN) Ameloblast (maturation) 4q13.3
Apin/odontogenic,
ameloblast-associated (ODAM)
Ameloblast (maturation) 4q13
New insights into the functions of enamel matrices 49maturation stage. These enamel matrix components are
considered important for enamel crystal formation. In fact,
AMEL and ENAM mutations are identified in patients with
amelogenesis imperfecta (AI), a common group of inherited
defects of dental enamel formation that exhibit marked
genetic and clinical heterogeneity, with at least 14 different
sub-types recognized on the basis of their clinical appearance
and mode of inheritance [4—6]. However, a recent study that
used a gene-targeting method and in vitro analysis showed
that these matrices also have a large number of biological
functions in addition to enamel formation, including bone
formation, tumorigenesis, and the regulation of stem cell
function. Mineralized tissue formation and maintenance are
controlled by matrix proteins such as several secretory cal-
cium-binding phospho-proteins (SCPPs), which are encoded
by SCPP genes clustered on human chromosome 4 [7]. Half of
these proteins, including bone sialoprotein, osteopontin,
dentin sialophosphoprotein, and dentin matrix protein, are
associated with bone and dentin formation, while the other
half of consists of enamel-associated proteins, including
AMBN, ENAM, AMTN, and Apin/ODAM (Table 1). They promote
mineral nucleation through calcium ion sequestration and
control crystal growth by adsorption onto growing crystal
surfaces [8]. Here, we present the functions of enamel matrix
molecules in enamel formations and review recently
reported new functions of these molecules in other tissues
and diseases.
2. Amelogenin (AMEL)
Tooth enamel is a highly organized hierarchical nano-compo-
site material consisting of parallel arrays of elongated apa-
titic crystallites that form an intricate three-dimensional
microstructure. Amelogenin (AMEL) is a highly conserved
protein secreted by ameloblasts that constitutes 90% of
the enamel matrix. It is also the most abundant protein in
the organic enamel matrix and has structural characteristics
that are indispensable for enamel formation. Genomic
sequence analysis of the AMEL gene in five primates and
three other mammals and FISH analysis on the comparison of
humans with seven other mammals revealed that the 5-prime
portion of the AMEL loci began to evolve from the commonancestor of extant mammals, whereas the 3-prime portion
evolved independently within different mammal species.
The boundary is marked by a transposon insertion in intron
2, which is shared by all of the examined species [9].
Mutations in the AMEL gene in humans and AMEL deficiency
in mice cause defective enamel [10] and result in the diverse
group of genetically altered conditions collectively known as AI
in humans. AMEL null mice showed remarkable resorption of
cementum and root dentin via the receptor activator of
nuclear factor-kappa B ligand-mediated osteoclastogenesis
[11], suggesting that AMEL is negative regulator of osteoclast
genesis [12]. In fact, in vivo application of AMEL suppresses
root resorption [13]. The enamel layer in AMEL null mice is
hypoplastic and missing a characteristic prism pattern, while it
has an elemental composition consistent with a hydroxyapa-
tite-like mineral [10], suggesting that AMEL is necessary for
enamel organization, but not mineral crystal initiation. A
tyr64-to-his missense mutation in the tri-tyrosyl domain of
the enamel extracellular matrix protein in mice (AMELX)
results in severe defects of enamel biomineralization asso-
ciated with an absence of the full-length AMEL protein in the
enamel matrix; this mutation also increases ameloblast apop-
tosis [14]. In that study, affected ameloblasts express, but fail
to secrete full-length AMEL, leading to engorgement of the
endoplasmic reticulum/Golgi apparatus, and both AMEL and
AMBN accumulated in the affected cells of mice. Furthermore,
the co-transfection of AMBN and mutant AMELX in cells reveals
intracellular abnormalities and increases cytotoxicity com-
pared with cells singly transfected with wild-type AMELX,
mutant AMELX, or AMBN, or co-transfected with both wild-
type AMELX and AMBN, indicating that intracellular protein—
protein interactions mediated via the amelogenin tri-tyrosyl
motif may be a key mechanistic factor underpinning the
molecular pathogenesis in this example of AI.
Abundant AMEL proteins are responsible for generating
proper enamel thickness and structure, and most of those
proteins include a conserved hydrophilic C-terminus. Mice
that express AMEL lacking the C-terminal show deficient
enamel in the molar teeth, suggesting that AMEL, especially
the C-terminus, is essential for proper enamel density,
volume, and organization [15]. AMEL regulates the formation
of these crystalline arrays via cooperative interactions with
50 S. Fukumoto et al.the forming mineral phase. Cryoelectron microscopy analysis
has shown that AMEL undergoes stepwise hierarchical self-
assembly. Furthermore, interactions between AMEL hydro-
philic C-terminal telopeptides are essential for oligomer
formation and subsequent steps of hierarchical self-assem-
bly. The pre-nucleation clusters subsequently fuse together
to form needle-shaped mineral particles, leading to the
formation of bundles of crystallites, the hallmark structural
organization of enamel forming at a nanoscale size [16].
AMEL is soluble at a low pH and self-assembles to form
higher order structures at physiological pH. In FTIR spectro-
scopy (FTIRS) studies of the pH-triggered assembly of recom-
binant porcine AMEL performed to elucidate the mechanisms
of its assembly and interactions with calcium phosphate
mineral, AMEL at a pH of 3.0 is found to exist in an unfolded
disordered state, while increases in pH lead to structural
ordering, manifested by increases in intra- and intermole-
cular beta-sheet structures and decreases in random coil and
beta-turns. AMEL assembled at a pH of 7.2 is also found to
contain large portions of extended intramolecular beta-sheet
structures, and interactions with minerals lead to a reduction
in protein structural organization. These findings indicate
that AMEL has an intrinsic structural flexibility to accommo-
date interactions with both forming and mature calcium
phosphate mineral phases and provide new insights into
the potential importance of AMEL—mineral interactions in
enamel biomineralization [17].
Recent studies have also revealed that AMEL has cell
signaling properties. Although the AMEL protein has been
described as a specific product of ameloblasts, recent find-
ings have shown that AMEL is expressed in bone marrow
stromal cells. Researchers have also demonstrated that
the full-length AMEL protein interacts with LAMP1, an AMEL
receptor, and increases the proliferation of mesenchymal
stem cells through the MAPK-ERK signaling pathway [18].
One of the AMEL splicing isoforms, leucine-rich amelogenin
peptide (LRAP), induces osteogenesis in osteoprogenitor
cells. LPAP activates the canonical Wnt signaling pathway
to induce the osteogenic differentiation of mouse ES cells
through the concerted regulation of Wnt agonists and antago-
nists. There is also a reciprocal relationship between osteo-
genic and adipogenic differentiation in bone marrow
mesenchymal stem cells; Wnt10b-mediated activation of
canonical Wnt signaling has also been shown to regulate
mesenchymal stem cell fate. Using the bone marrow stromal
cell line ST2, LRAP activates the canonical Wnt/b-catenin
signaling pathway. LRAP treatment also elevates the Wnt10b
expression level, whereas Wnt10b knockdown by siRNA abro-
gates its effects, indicating that LRAP promotes mesenchy-
mal stem cells’ osteogenesis at the expense of adipogenesis
by up-regulating Wnt10b expression to activate Wnt signaling
[19].
Collagen I and AMEL are major extracellular organic
matrix proteins of dentin and enamel, respectively, which
represent two mineralized tissues that comprise the tooth
crown. Both are present at the dentin—enamel boundary, a
remarkably robust interface that holds dentin and enamel
together. Collagen fibrils guide the assembly of AMEL into an
elongated chain or filament-like structures oriented along
the long axes of the fibrils. The interactions between col-
lagen fibrils and amelogenin—calcium phosphate mineral
complexes lead to the oriented deposition of elongatedamorphous mineral particles along the fibril axes, triggering
the mineralization of the bulk of collagen fibrils, indicating
that interactions between collagen and AMEL play an impor-
tant role in forming the dentin—enamel boundary that pro-
vides structural continuity between dentin and enamel [20].
Further, posttranslational modification like glycosylation,
phosphorylation and sulfation is important for protein func-
tion. Tyrosyl motif in amelogenin binds N-acetyl-D-glucosa-
mine and N-acetyl-D-glucosamine-mimicking peptide motif of
cytokeratin [21]. In enamel formation, amelogenin interacts
with sytokeratin 14 [22] and binds to ameloblastin via ame-
logenin tyrosyl motif [23]. That domain has an affinity for
binding N-acetyl-D-glucosamine of cleavage products of
enamelin, suggesting amelogenin—enamelin interaction
[24].
3. Ameloblastin (AMBN)
Ameloblastin (AMBN) is a non-AMEL protein that is highly
expressed by ameloblasts in the secretory stage. AMBN-null
mice develop severe enamel hypoplasia (Fig. 2) [25]. Further-
more, though the dental epithelium in these mice differenti-
ates into ameloblasts, the cells become detached from the
matrix and subsequently lose cell polarity; thus, proliferation
is resumed. In addition, recombinant AMBN binds to amelo-
blasts and inhibits cell proliferation, indicating that AMBN is
an essential cell adhesion molecule for amelogenesis and
plays a role in maintaining secretory-stage ameloblasts by
binding to ameloblasts and inhibiting proliferation [25].
AMBN expression is regulated by BMP2 and neurotrophic
factor NT-4, while NT-4 and its receptor TrkB regulate the
differentiation of ameloblasts in tooth development [26].
Recent studies have shown that NT-4-induced AMBN expres-
sion is regulated by glycosphingolipids. The exogenous glyco-
sphingolipids GM3 and LacCer in dental epithelial cells induce
AMBN expression. It is also interesting to note that GM3
synergistically enhances NT-4-mediated AMBN expression.
Furthermore, depleting the glycosphingolipids from dental
epithelial cells using D-PDMP inhibits AMBN expression as well
as ERK1/2 phosphorylation. In contrast, adding exogenous
GM3 or LacCer rescues the phosphorylation of ERK1/2
repressed by pre-treatment with D-PDMP, suggesting that
GM3 and LacCer are essential for the NT-4-mediated induc-
tion of AMBN expression and contribute to dental epithelial
cells’ differentiation into ameloblasts [27].
Although first discovered in ameloblasts [28], AMBN is also
expressed by osteoblasts [29], cementoblasts [30], and
epithelial rests of Malassez in the periodontal ligament
[31]. The AMBN protein sequence features a fibronectin
interaction site [32] and heparin-binding domains [33]. In
rodents, there is a potential a2b1 integrin-binding domain
and a thrombospondin cell adhesion motif in the AMBN
protein [34]. The effect of AMBN on cell adhesion involves
RhoA signaling and cell cycle progression through p27 [35].
AMBN is expressed in mouse calvarial bone and adjacent
condensed mesenchyme, and an AMBN transgenic mouse
model shows delayed posterior frontal suture fusion and
incomplete suture closure. Furthermore, AMBN-overexpres-
sing mice show reduced cell proliferation in suture blastemas
and mesenchymal cells from posterior frontal sutures. In
these mice, the expression of Msx2 in calvaria and suture
Figure 2 X-ray analysis of an AMBN knockout mouse shows severe enamel hypoplasia. Tooth cusps were flat because of attrition. The
entire craniofacial bone size was not different than that of a wild-type mouse. Similar tooth phenotypes were observed in AMEL and
ENAM mutant mice.
New insights into the functions of enamel matrices 51mesenchymal cells is decreased. Finally, AMBN overexpres-
sion significantly reduces the expression of Msx2 downstream
target molecules, including osteogenic transcription factors
Runx2 and Osterix. Together, these results suggest that AMBN
plays a crucial role in the regulation of cranial bone growth
and suture closure via Msx2 suppression and proliferation
inhibition [36].
Tooth root formation begins after the completion of crown
morphogenesis. At the edge of the tooth crown end, inner
and outer enamel epithelia form the Hertwig’s epithelial root
sheath (HERS), which extends along with dental follicular
tissue for root formation. AMBN is a matrix protein secreted
by ameloblasts and HERS-derived cells. In one study, AMBN
siRNA treatment of 10-day-postnatal molars was found to
inhibit root formation. Furthermore, HERS in these mice
revealed a multilayered appearance, and BrdU-positive cells
were increased in the outer layers, indicating that AMBN
regulates HERS cell proliferation and functions as a trigger for
normal root formation [37].
Dental epithelial tumor formation has been observed in
AMBN knockout mice [25], while AMBN has also been shown to
be expressed in osteosarcoma cells. AMBN binds to CD63, a
member of the transmembrane-4 glycoprotein superfamily,
and promotes CD63 binding to integrin b1. Furthermore, the
interaction between CD63 and integrin b1 induces Src kinase
inactivation via the binding of CD63 to Src, indicating that
AMBN is expressed in osteoblasts and functions as a promoting
factor for osteogenic differentiation via a novel pathway
through an interaction between CD63 and integrin b1 [38].4. Enamelin (ENAM)
Enamelin (ENAM) is a secreted glycoprotein known to be
critical for dental enamel formation. The analysis of a
three-generation family with an autosomal-dominant smooth
hypoplastic form of AI showed a mutation in the splice donor
site of intron 7 of the ENAM gene in affected family members
[39]. Using N-ethyl-N-nitrosourea (ENU), an ENAM mutation
mouse model [40] showed AI-like phenotypes in the incisors
and molars. Ameloblasts in ENAM null mice develop atypical
features that include the absence of a Tomes’ process, an
expanded endoplasmic reticulum, an apparent loss of polar-
ity, and a pooling of extracellular matrix in all directions,
including between ameloblasts and the stratum interme-
dium. Ameloblast apoptosis has been observed in these mice
starting in the secretory stage and with no apparent altera-
tion in cell proliferation. In the absence of ENAM, ameloblasts
undergo pathological changes early in the secretory stage,
tooth surface detachment, apoptosis, and ectopic calcifica-
tion formation, both outside and inside the dystrophic
enamel organ [41]. Furthermore, ENAM null mice have alveo-
lar bone height reduction [42], indicating that ENAM may be
important for calcification and bone formation.
b-Catenin/LEF1 is a key transcriptional complex involved
in tooth development and bone formation via Wnt. The 50-
flanking region of the mouse ENAM gene contains two con-
served LEF1 responsive elements that may augment its
transcriptional activity. Further, Wnt/b-Catenin signaling
might function in ENAM expression by direct interactions
52 S. Fukumoto et al.through these two elements of the ENAM gene in ameloblast-
like cells [43].
5. Amelotin (AMTN) and Apin/ODAM
Amelotin (AMTN) is an enamel matrix protein originally
identified by the differential display PCR assays of various
micro-dissected dental organ cell types obtained from incisor
teeth. The predicted translated protein sequence is unique
and shows a significant homology only with its human ortho-
log. The AMTN gene in mice and humans displays a similar
exon—intron structure and is located in loci on chromosomes
5 and 4, respectively. AMTN mutations are associated with
various forms of AI. AMTN mRNA expression is restricted to
the maturation stage of ameloblasts in developing murine
molars and incisors. In addition, the AMTN protein is effi-
ciently secreted from cultured transfected cells, indicating
that AMTN is an extracellular matrix molecule produced by
ameloblasts [44]. In addition, the AMTN gene is conserved in
mammals, while it is absent in fish, birds, and amphibians
[45].
AMTN expression is detected in a transient fashion during
ameloblast differentiation in molars. The expression level
declines at the time of tooth eruption. Prominent AMTN
expression in the maturation stage of ameloblasts in con-
tinuously erupting incisors persists into adulthood, whereas
AMEL, AMBN, and ENAM are predominantly found during the
early secretory stage. Furthermore, odontogenic ameloblast-
associated amyloid in Pindborg tumors and kallikrein 4
expression in ameloblasts’ maturation stage were found to
parallel that of AMTN. Secreted AMTN is also detected at the
interface between ameloblasts and mineralized enamel.
AMTN transgenic mice under the control of the amelogenin
gene promoter show a histological appearance similar to that
of ameloblasts or supporting cellular structures, while
expressions of the enamel proteins AMEL and AMBN are not
altered [46]. These results suggest that AMTN plays a primary
role in the late stages of enamel mineralization [47].
Apin/ODAM is identified in calcified epithelial odontogenic
tumor (CEOT) specimens. Its subcellular localization varies
during ameloblast differentiation, though it is stage-specific.
Apin/ODAM mRNA is not expressed in pre-ameloblasts and
only weakly expressed in secretory ameloblasts, whereas
expression is strong in maturation-stage ameloblasts as well
as the junctional epithelium attached to the enamel of
erupted molars. In maturation-stage ameloblasts, Apin/
ODAM protein is conspicuous in the supranuclear area (Golgi
complex) of smooth-ended ameloblasts as well as in both the
supranuclear area and the ruffle end of ruffle-ended amelo-
blasts. Furthermore, its overexpression and inactivation
cause an increase in matrix metalloproteinase-20 (MMP-20)
expression and a decrease in tuftelin expression, indicating
that Apin/ODAM plays a functional role in enamel minerali-
zation and maturation that is mediated by the expression of
MMP-20 and tuftelin [48].
The Apin/ODAM gene is highly conserved in mammals,
while it is absent in fish, birds, and amphibians, as seen with
AMTN [49]. The Apin/ODAM protein is modified in a post-
translational manner, which is consistent with the presence
of predicted sites for phosphorylation and O-linked glycosy-
lation. The presence of Apin/ODAM at cell-tooth interfacessuggests that it is involved in adhesive mechanisms active at
these sites, while its presence in other epithelial tissues
indicates that it likely possesses broader physiological roles
[49].
The expression of Apin/ODAM is increased in the secre-
tory-stage ameloblasts of AMTN transgenic animals, indicat-
ing that AMTN may regulate its expression [46]. Both Apin/
ODAM and AMTN are localized in the basal lamina of matura-
tion-stage ameloblasts. At the beginning of maturation, a
concentration of Apin/ODAM exists on the cell side of the
basal lamina, while AMTN appears to be more concentrated
on the enamel side. In the late maturation stage, such
differential distribution is no longer apparent [50]. Using
two-yeast hybrid screening systems, AMTN interacts with
itself and ODAM, but not with AMEL, AMBN, or ENAM. Using
ODAM as bait, the interaction with AMTN is confirmed. ODAM
binds to itself and AMBN, as well as weakly to AMEL, but not to
ENAM. The distinct expressions of AMTN and ODAM and their
interaction are involved in defining the enamel microstruc-
ture on the enamel’s surface [51].
6. Evolution of enamel matrix genes
Most ECM proteins contain domain structures such as EGF-
like, fibronectin type III (FN3), laminin G (LamG), Ig-like,
thrombospondin (TSPN), von Willebrand factor A (VWA), and
collagenous domains. Variations in their arrangements give
rise to the characteristic features of ECM proteins. Approxi-
mately 300 genes are identified that are involved in coding
ECM proteins in mammals by searching domains character-
istic to ECM molecules through the whole genome sequence
[52]. The total number of ECM molecules corresponds to
about 1.5% of proteasomes, a list of all proteins expressed
by the genome. ECM proteins typically consist of repeated
domains, which are coded in the genome as separate exonic
units and evolve through multiple processes such as exon
duplication and shuffling, and gene duplication and conver-
sion [53,54]. Analyses of the genomes in different organisms
suggest that some ECM molecules in mammals retain ancient
forms, which are found in all metazoans, while some are
derived from newer proteins.
Mineralization is one of the hallmark processes that has
taken place during vertebrate evolution. Three major miner-
alized tissues, enamel, dentin, and bone, have evolved over
500 million years likely from a common ancestral process
[55]. The genes for enamel matrix proteins expressed by
ameloblasts, AMEL, ENAM, AMBN, AMTN, and Apin/ODAM,
have evolved from a common ancestral gene encoding an
SCPP [56,57]. Enamel matrix genes are clustered on human
chromosome 4q13. However, AMEL is located on sex chromo-
somes. AMELX and AMELY are located on the X and Y chromo-
somes, respectively. About 90% of the AMEL transcripts are
expressed on the X locus. SCPP family genes are also mapped
on human chromosome 4. Analysis of the enamel matrix
genes in different species has shown that ENEM is the most
ancient gene and the other four enamel genes are derived
from ENEM. AMEL is derived from AMBN and was later trans-
located to sex chromosomes [57]. The chromosomal synteny
of these genes is conserved in primates and rodents. In birds,
which lost their teeth about 100 million years ago, the
enamel matrix gene cluster is lacking [58].
New insights into the functions of enamel matrices 537. Conclusion
Initially, enamel matrices were identified as enamel-specific
molecules. However, the expression of enamel matrix pro-
teins has been shown in other tissues outside of the tooth
germ as a result of improved sensitivity in detection analyses.
Furthermore, the overexpression or knockdown of these
matrices not only causes enamel defects, but also aberrant
tooth roots, bone formation, and tumor phenotypes. The
enamel matrix proteins are evolutionally related, but have
distinct functions. The newly identified activities of enamel
matrix proteins will provide a better understanding of the
mechanisms of craniofacial development, including enamel,
dentin, and craniofacial bone formation.
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